Covestor LTD Viatris Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Viatris Inc stock. As of the latest transaction made, Covestor LTD holds 21,183 shares of VTRS stock, worth $275,379. This represents 0.15% of its overall portfolio holdings.

Number of Shares

21,183

Previous 15,393 37.61%

Holding current value

$275,379

Previous $164,000 50.0%

% of portfolio

0.15%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$10.32 - $12.13 $59,752 - $70,232	5,790 Added 37.61%	21,183 $246,000
Q2 2024 Aug 09, 2024	SELL	$10.05 - $12.02 $61,294 - $73,309	-6,099 Reduced 28.38%	15,393 $164,000
Q1 2024 May 10, 2024	SELL	$11.27 - $13.53 $5,871 - $7,049	-521 Reduced 2.37%	21,492 $256,000
Q4 2023 Feb 09, 2024	SELL	$8.77 - $10.85 $368 - $455	-42 Reduced 0.19%	22,013 $238,000
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $16,245 - $19,226	1,694 Added 8.32%	22,055 $217,000
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $26,446 - $30,170	2,932 Added 16.82%	20,361 $203,000
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $12,438 - $16,575	-1,352 Reduced 7.2%	17,429 $168,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $49,573 - $65,718	5,685 Added 43.41%	18,781 $209,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $101,166 - $132,780	11,930 Added 1023.16%	13,096 $112,000
Q2 2022 Aug 10, 2022	SELL	$9.95 - $12.27 $318 - $392	-32 Reduced 2.67%	1,166 $12,000
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $4,267 - $6,699	435 Added 57.01%	1,198 $13,000
Q4 2021 Feb 10, 2022	BUY	$12.09 - $14.68 $9,224 - $11,200	763 New	763 $10,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account